Cancer Research Meeting Calendar Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dennis, J. L.
Right arrow Articles by Oien, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dennis, J. L.
Right arrow Articles by Oien, K. A.
[Cancer Research 62, 5999-6005, November 1, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Identification from Public Data of Molecular Markers of Adenocarcinoma Characteristic of the Site of Origin1 ,2

Jayne L. Dennis, J. Keith Vass, Ernst C. Wit, W. Nicol Keith and Karin A. Oien3

Cancer Research UK Department of Medical Oncology, University of Glasgow, Cancer Research UK Beatson Laboratories, Glasgow G61 1BD, Scotland, United Kingdom [J. L. D., W. N. K., K. A. O.]; Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Glasgow G61 1BD, Scotland, United Kingdom [J. K. V.]; Department of Statistics, University of Glasgow, Glasgow G12 8QW, Scotland, United Kingdom [E. C. W.]; and University Department of Pathology, Glasgow Royal Infirmary, Glasgow G4 0SF, Scotland, United Kingdom [K. A. O.]

Patients presenting with metastatic adenocarcinoma of unknown origin are a common clinical problem. Their optimal management and therapy are facilitated by identification of the primary site, yet histologically these tumors are almost identical. Better tumor markers are needed to enable the assignment of metastases to likely sites of origin. In this study, hierarchical clustering of public serial analysis of gene expression data showed that adenocarcinomas and their metastases cluster according to their site of origin. A novel bioinformatic approach was developed to exploit the differences between these clusters, using diverse sources: public expression data from serial analysis of gene expression and digital differential display; and the published literature, including microarray studies. Sixty-one candidate tumor markers with expression predicted to be characteristic of the site of origin were identified. Eleven genes were tested by reverse transcription-PCR in primary adenocarcinomas from a range of sites, and seven (64%) were site-restricted. Analysis of public gene expression data sets is a powerful method for the identification of clinically relevant tumor markers.




This article has been cited by other articles:


Home page
 BioinformaticsHome page
G. Quon and Q. Morris
ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencing
Bioinformatics, November 1, 2009; 25(21): 2882 - 2889.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. A. Oien and T.R. J. Evans
Raising the Profile of Cancer of Unknown Primary
J. Clin. Oncol., September 20, 2008; 26(27): 4373 - 4375.
[Full Text] [PDF]

Home page
 JCOHome page
H. M. Horlings, R. K. van Laar, J.-M. Kerst, H. H. Helgason, J. Wesseling, J. J.M. van der Hoeven, M. O. Warmoes, A. Floore, A. Witteveen, J. Lahti-Domenici, et al.
Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown Primary
J. Clin. Oncol., September 20, 2008; 26(27): 4435 - 4441.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
G. Pentheroudakis, E. Briasoulis, and N. Pavlidis
Cancer of Unknown Primary Site: Missing Primary or Missing Biology?
Oncologist, April 1, 2007; 12(4): 418 - 425.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
D. Talantov, J. Baden, T. Jatkoe, K. Hahn, J. Yu, Y. Rajpurohit, Y. Jiang, C. Choi, J. S. Ross, D. Atkins, et al.
A Quantitative Reverse Transcriptase-Polymerase Chain Reaction Assay to Identify Metastatic Carcinoma Tissue of Origin
J. Mol. Diagn., July 1, 2006; 8(3): 320 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Fluck, C. Dapp, S. Schmutz, E. Wit, and H. Hoppeler
Transcriptional profiling of tissue plasticity: role of shifts in gene expression and technical limitations
J Appl Physiol, August 1, 2005; 99(2): 397 - 413.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. D. Cohen, P. P. Doran, S. M. Blattner, M. Merkle, G. Q. Wang, H. Schmid, P. W. Mathieson, M. A. Saleem, A. Henger, M. P. Rastaldi, et al.
Sam68-Like Mammalian Protein 2, Identified by Digital Differential Display as Expressed by Podocytes, Is Induced in Proteinuria and Involved in Splice Site Selection of Vascular Endothelial Growth Factor
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1958 - 1965.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. W. Tothill, A. Kowalczyk, D. Rischin, A. Bousioutas, I. Haviv, R. K. van Laar, P. M. Waring, J. Zalcberg, R. Ward, A. V. Biankin, et al.
An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin
Cancer Res., May 15, 2005; 65(10): 4031 - 4040.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. L. Dennis, T. R. Hvidsten, E. C. Wit, J. Komorowski, A. K. Bell, I. Downie, J. Mooney, C. Verbeke, C. Bellamy, W. N. Keith, et al.
Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm
Clin. Cancer Res., May 15, 2005; 11(10): 3766 - 3772.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. G. Talbot, C. Estilo, E. Maghami, I. S. Sarkaria, D. K. Pham, P. O-charoenrat, N. D. Socci, I. Ngai, D. Carlson, R. Ghossein, et al.
Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung
Cancer Res., April 15, 2005; 65(8): 3063 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
D. M. Mintzer, M. Warhol, A.-M. Martin, and G. Greene
Cancer of Unknown Primary: Changing Approaches. A Multidisciplinary Case Presentation from the Joan Karnell Cancer Center of Pennsylvania Hospital
Oncologist, June 1, 2004; 9(3): 330 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. S. Dahlberg, L. F. Ferrin, S. M. Grindle, C. M. Nelson, C. D. Hoang, and B. Jacobson
Gene expression profiles in esophageal adenocarcinoma
Ann. Thorac. Surg., March 1, 2004; 77(3): 1008 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Bardelli, S. Saha, J. A. Sager, K. E. Romans, B. Xin, S. D. Markowitz, C. Lengauer, V. E. Velculescu, K. W. Kinzler, and B. Vogelstein
PRL-3 Expression in Metastatic Cancers
Clin. Cancer Res., November 15, 2003; 9(15): 5607 - 5615.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Balana, J.-L. Manzano, I. Moreno, B. Cirauqui, A. Abad, A. Font, J.-L. Mate, and R. Rosell
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site
Ann. Onc., September 1, 2003; 14(9): 1425 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Buckhaults, Z. Zhang, Y.-C. Chen, T.-L. Wang, B. St. Croix, S. Saha, A. Bardelli, P. J. Morin, K. Polyak, R. H. Hruban, et al.
Identifying Tumor Origin Using a Gene Expression-based Classification Map
Cancer Res., July 15, 2003; 63(14): 4144 - 4149.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.